{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T17:42:57Z","timestamp":1792172577891,"version":"4.4.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2007,4,1]],"date-time":"2007-04-01T00:00:00Z","timestamp":1175385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,5]],"date-time":"2019-12-05T00:00:00Z","timestamp":1575504000000},"content-version":"vor","delay-in-days":4631,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2007,4]]},"DOI":"10.1093\/annonc\/mdl478","type":"journal-article","created":{"date-parts":[[2007,1,18]],"date-time":"2007-01-18T01:24:52Z","timestamp":1169083492000},"page":"689-693","source":"Crossref","is-referenced-by-count":83,"title":["Venlafaxine is superior to clonidine as treatment of hot flashes in breast cancer patients\u2014a double-blind, randomized study"],"prefix":"10.1016","volume":"18","author":[{"given":"S.","family":"Loibl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Schwedler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"von Minckwitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Strohmeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.M.","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Kaufmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1093\/annonc\/mdl478_bb0010","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1002\/(SICI)1097-0142(19980501)82:9<1682::AID-CNCR14>3.0.CO;2-0","article-title":"Hot flashes in postmenopausal women treated for breast carcinoma: prevalence, severity, correlates, management, and relation to quality of life","volume":"82","author":"Carpenter","year":"1998","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mdl478_bb0015","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1200\/JCO.1995.13.11.2737","article-title":"Prevalence of menopausal symptoms among women with a history of breast cancer and attitudes toward estrogen replacement therapy","volume":"13","author":"Couzi","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdl478_bb0020","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/S0140-6736(77)92716-7","article-title":"Ovarian function in patients receiving adjuvant chemotherapy for breast cancer","volume":"1","author":"Rose","year":"1977","journal-title":"Lancet"},{"key":"10.1093\/annonc\/mdl478_bb0025","doi-asserted-by":"crossref","first-page":"4510","DOI":"10.1200\/JCO.2003.11.064","volume":"21","author":"de Haes","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdl478_bb0030","doi-asserted-by":"crossref","first-page":"4261","DOI":"10.1200\/JCO.2004.08.029","article-title":"Quality of life of postmenopausal women in the Arimidex, Tamoxifen, Alone or in Combination (ATAC) Adjuvant Breast Cancer Trial","volume":"22","author":"Fallowfield","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdl478_bb0035","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0378-5122(83)90008-7","article-title":"Dose response and withdrawal effects on climacteric symptoms after hormone replacement therapy. A placebo-controlled therapeutic trial","volume":"5","author":"Jensen","year":"1983","journal-title":"Maturitas"},{"key":"10.1093\/annonc\/mdl478_bb0040","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risk and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial","volume":"288","author":"Rossouw","year":"2002","journal-title":"JAMA"},{"key":"10.1093\/annonc\/mdl478_bb0045","first-page":"419","article-title":"HABITS: (hormone replacement therapy after breast cancer\u2014is it safe?), a randomised comparison: trial stopped","volume":"363","author":"Holmberg","year":"2003","journal-title":"Lancet"},{"key":"10.1093\/annonc\/mdl478_bb0050","doi-asserted-by":"crossref","first-page":"3991","DOI":"10.1200\/JCO.2005.04.3745","article-title":"Influence of hormone replacement therapy on tamoxifen-induced vasomotor symptoms","volume":"24","author":"Sestak","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdl478_bb0055","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1016\/S0140-6736(02)11774-0","article-title":"Hot flushes","volume":"360","author":"Stearns","year":"2001","journal-title":"Lancet"},{"key":"10.1093\/annonc\/mdl478_bb0060","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1200\/JCO.1994.12.1.155","article-title":"Transdermal clonidine for ameliorating tamoxifen-induced hot flashes","volume":"12","author":"Goldberg","year":"1994","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdl478_bb0065","doi-asserted-by":"crossref","first-page":"788","DOI":"10.7326\/0003-4819-132-10-200005160-00004","article-title":"Oral clonidine in postmenopausal patients with breast cancer experiencing tamoxifen induced hot flashes: a university of Rochester Cancer Center Community Clinical Oncology Program Study","volume":"132","author":"Pandya","year":"2000","journal-title":"Ann Intern Med"},{"key":"10.1093\/annonc\/mdl478_bb0070","first-page":"583","article-title":"Effect of clonidine on hot flashes in postmenopausal women","volume":"60","author":"Laufer","year":"1982","journal-title":"Obstet Gynecol"},{"key":"10.1093\/annonc\/mdl478_bb0075","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/S0140-6736(00)03403-6","article-title":"Venlafaxine in management of hot flashes in survivors of breast cancer: a randomized controlled trial","volume":"356","author":"Loprinzi","year":"2000","journal-title":"Lancet"},{"key":"10.1093\/annonc\/mdl478_bb0080","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1200\/JCO.2002.20.6.1578","article-title":"Phase III evaluation of fluoxetine for treatment of hot flashes","volume":"20","author":"Loprinzi","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdl478_bb0085","doi-asserted-by":"crossref","first-page":"6919","DOI":"10.1200\/JCO.2005.10.081","article-title":"Paroxetine is an effective treatment for hot flashes: results from a prospective randomized clinical trial","volume":"23","author":"Stearns","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdl478_bb0090","doi-asserted-by":"crossref","first-page":"4280","DOI":"10.1200\/JCO.2001.19.23.4280","article-title":"Methodologic lessons learned form hot flash studies","volume":"19","author":"Sloan","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdl478_bb0095","series-title":"Applied Analysis of Variance on Behavioural Sciences","first-page":"297","author":"O'Brien","year":"1983"},{"key":"10.1093\/annonc\/mdl478_bb0100","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1200\/JCO.1998.16.7.2377","article-title":"Pilot evaluation of venlafaxine hydrochloride for the therapy of hot flashes in cancer survivors","volume":"16","author":"Loprinzi","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdl478_bb0105","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1111\/j.1471-0528.1985.tb03032.x","article-title":"Effect of oral clonidine on human cardiovascular responsiveness: a possible explanation of the therapeutic action of the drug in menopausal flushing and migraine","volume":"92","author":"Ginsburg","year":"1985","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1093\/annonc\/mdl478_bb0110","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/00042192-200512010-00006","article-title":"Citalopram and fluoxetine in the treatment of postmenopausal symptoms: a prospective, randomized, 9-month, placebo-controlled, double-blind study","volume":"12","author":"Suvanto-Luukkonen","year":"2005","journal-title":"Menopause"},{"key":"10.1093\/annonc\/mdl478_bb0115","doi-asserted-by":"crossref","DOI":"10.1200\/jco.2005.23.16_suppl.8016","article-title":"Do women with primary breast cancer who experience chemotherapy-induced menopause have worse symptoms than those due to natural menopause?","author":"Tchen","year":"2005","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.1093\/annonc\/mdl478_bb0120","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.maturitas.2004.04.009","article-title":"Oral dryness, nocturia and the menopause","volume":"50","author":"Asplund","year":"2005","journal-title":"Maturitas"},{"key":"10.1093\/annonc\/mdl478_bb0125","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1001\/jama.289.21.2827","article-title":"Paroxetine controlled release in the treatment of menopausal hot flash: a randomized controlled trial","volume":"289","author":"Stearns","year":"2003","journal-title":"JAMA"},{"key":"10.1093\/annonc\/mdl478_bb0130","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1093\/jnci\/djg108","article-title":"Active tamoxifen metabolite plasma concentrations after coadministration of tamoxifen and the selective serotonin reuptake inhibitor paroxetine","volume":"95","author":"Stearns","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"10.1093\/annonc\/mdl478_bb0135","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1093\/jnci\/dji005","article-title":"CYP2D6 genotype, antidepressant use, and tamoxifen metabolism during adjuvant breast cancer treatment","volume":"97","author":"Jin","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"10.1093\/annonc\/mdl478_bb0140","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.clpt.2006.03.013","article-title":"Quantitative effect of CYP2D6 genotype and inhibitors on tamoxifen metabolism: implication for optimizing of breast cancer treatment","volume":"80","author":"Borges","year":"2006","journal-title":"Clin Pharmacol Ther"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092375341937869X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092375341937869X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/18\/4\/689\/308365\/mdl478.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T18:10:17Z","timestamp":1635790217000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092375341937869X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,4]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,4]]}},"alternative-id":["S092375341937869X"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/mdl478","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2007,4]]}}}